CG
ABBV icon

Curat Global’s AbbVie ABBV Stock Holding History

Curat Global’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
5,767
+1,796
+45% +$398K 1.24% 16
2025
Q4 		$907K Sell
3,971
-2,478
-38% -$564K 1.01% 20
2025
Q3 		$1.49M Buy
6,449
+2
+0% +$407 1.4% 14
2025
Q2 		$1.2M Buy
6,447
+1,875
+41% +$348K 1.14% 19
2025
Q1 		$958K Buy
+4,572
New +$889K 1.17% 17

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Curat Global's ABBV Position: Q1 2026 in Review

Curat Global increased its AbbVie (ABBV) stake by 45% in Q1 2026, buying an estimated $398K and bringing the position to 5,767 shares worth $1.25M. The position accounts for 1.24% of the portfolio, ranked #16.

Curat Global first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.49M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Curat Global held 5,767 shares of AbbVie worth $1.25M as of Q1 2026.
  • Curat Global bought 1,796 AbbVie shares in Q1 2026, an estimated $398K.
  • AbbVie made up 1.24% of Curat Global's portfolio in Q1 2026, its #16 holding.
  • Curat Global first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • Curat Global's AbbVie position peaked at $1.49M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Curat Global's 13F filing for Q1 2026, filed 21 Apr 2026.